CD274 and neoplasm: Among 46 treatment-naïve samples tested locally for PD-L1 expression, 14 (30%) had a high-level tumor proportion score (TPS ≥50%), 17 (37%) intermediate level (1%-49%), and 15 (33%) low level (<1%).